← Insider buys
MCRB

Seres Therapeutics, Inc. · Healthcare

President and CEO Roger Pomerantz sold $295K of Seres Therapeutics, Inc.

Sold$295,065
$9.12Price
32,336Shares
−12%Stake

What MCRB did after the filing

Prices for MCRB after this filing aren't in yet.

Traded Fri, Jul 6. Filed Tue, Jul 10, 5:49 PM ET, after the close. Not investment advice.